Specialised Diagnostic testing for early invasive breast cancer pat

A Contract Award Notice
by SOMERSET NHS FOUNDATION TRUST

Source
Find a Tender
Type
Contract (Services)
Duration
not specified
Value
£185K
Sector
HEALTH
Published
17 Mar 2025
Delivery
not specified
Deadline
n/a

Concepts

Location

Somerset: Musgrove Park Hospital

Geochart for 1 buyers and 1 suppliers

1 buyer

1 supplier

Description

The Oncotype DX Breast Recurrence Score.

Total Quantity or Scope

Oncotype DX genomic testing for breast cancer.This notice is confirmation of an award having been made based on a framework agreement and without competition.The lifetime value of the contract is expected to be £184,950.00.The contract dates are 12 March 2025 to 11 March 2026. This is an existing service with an existing provider.

Award Detail

1 Exact Sciences (London)
  • Reference: 009688-2025-1
  • Value: £184,950

Award Criteria

Criteria as described in the framework agreement 100

CPV Codes

  • 85111800 - Pathology services

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.The award decision-makers were Manager Radiology, Pathology, Therapy, Orthotics & Dietetics.There were no known conflicts or potential conflicts of interest of individuals making the decision.

Reference

Domains